Subscribe today to receive notice of our latest thought leadership, articles, blogs and updates.
Insights
Open conversations, knowledge sharing, and fresh ideas promote positive change and transparency
Our latest blog posts, articles and podcasts
Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.
|
October 04, 2023 · Public Policy & Regulatory Affairs Team
Brief updates include Colorado furthering limits on physician dispensing in work comp, California work comp bill requiring in-state licensure for UR physicians on hold, Arizona Fee Schedule features new DMEPOS requirements, Tennessee activates Certified Physician Program and New York PTSD bill keeps moving. Read more... |
|
September 27, 2023 · Optum Workers' Comp and Auto No-Fault
As the media focuses on PBM pricing transparency, it’s important to consider all the benefits PBMs bring to the table. Read more... |
|
September 20, 2023 · Clinical Team
Zavzpret – indicated for the acute treatment of migraine with or without aura in adults – is now available as a 10 mg nasal spray device. Read more... |
|
|
September 15, 2023 · Clinical Team
According to the U.S. Food and Drug Administration (FDA), Duexis — a single-tablet combination product containing ibuprofen, a nonsteroidal anti‐inflammatory drug (NSAID), and famotidine, a histamine H2–receptor blocker — will no longer be manufactured. Read more... |
|
|
September 13, 2023 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
September 01, 2023 · Clinical Team
Earlier this year, the American Geriatrics Society (AGS) published an update to the AGS Beers Criteria® for potentially inappropriate medication (PIM) use in older adults (65 years of age and older). Older adults are more likely to experience unwanted adverse effects and be more sensitive to certain medications. Read more... |
Page 6 of 7